Investor profile
Mira Chaurushiya
Accelerator, Syndicate / Angel group, Venture capital & Fellow, Class 21 at Kauffman Fellows, Managing Director at Westlake BioPartners®
Mira Chaurushiya is a Managing Director at Westlake BioPartners®, whose known portfolio counts 9 companies.
Is Mira Chaurushiya a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
Contacts
Affiliated funds' portfolios
Fellow, Class 21 at Kauffman Fellows, whose known portfolio counts 5 companies
- Ligandal
- Catalog
- Flash
- Sidecar Health
- Elves
Managing Director at Westlake BioPartners®, whose known portfolio counts 9 companies
- Star Therapeutics
- Electra Therapeutics
- ArsenalBio
- Latigo Biotherapeutics
- Neuron23
- Recludix Pharma
- AllRock Bio
- Borealis Biosciences
- Kate Therapeutics
Investor Profile
Founders in the listed sectors FinTech, Hardware, Healthcare and Real Estate, and focus areas 3D Technology, Asset Management, Biotech and Cell & Gene Therapy fall inside that listing.
Westlake BioPartners® appears in Growth, Series A and Series B rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Mira Chaurushiya is worth approaching.
Colleagues
Showing 20 of 192
Konstantin Vinogradov
Fellow - Class 30
London, United Kingdom
Heather Hartnett
Affiliated
New York, United States
Amit Anand
Kauffman Fellow
Singapore
Ashley Mayer
Kauffman Fellows, Class 27
Brooklyn, United States
Erica Duignan Minnihan
Kauffman Fellow
New York City, United States
Omar Darwazah
Investor
New York, United States
Chris McCann
Kauffman Fellows - Class 30
San Francisco, United States
Antonia Rojas Eing
Kauffman Fellow, Class 25
Mexico City
Bedy Yang
Kauffman Fellow
San Francisco, United States
Luis X Barrios
Class 20
Mexico City
Thad Langford
Kauffman Fellow Class 22
Kansas City, United States
Sherman Williams II
Class 26
New York, United States
Henrik Wetter Sanchez
Kauffman Fellow (Class 28)
London, United Kingdom
Gyan Kapur
Kauffman Fellow (Class 27)
New York, United States
Reshma Sohoni
Fellow
London, United Kingdom
Daniel Kimerling
Fellow
Albuquerque, United States
Dan Malven
Member
Chicago, United States
Trish Costello
CEO/CEO Emeritus
San Mateo, United States
Amal Dokhan
Kauffman fellow (Class 27)
Riyadh, Saudi Arabia
Deena Shakir
Kauffman Fellow - Class 23
San Francisco, United States
Frequently asked questions
Who is Mira Chaurushiya?
Mira Chaurushiya is an accelerator partner and syndicate member based in San Francisco, California, United States, listed as Managing Director at Westlake BioPartners®. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Mira Chaurushiya personally.
What does Mira Chaurushiya invest in?
Listed sectors include FinTech, Hardware, Healthcare and Real Estate; listed focus areas include 3D Technology, Asset Management, Biotech and Cell & Gene Therapy. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Mira Chaurushiya invest at?
Westlake BioPartners® appears in Growth, Series A and Series B rounds across its known deals, and Mira Chaurushiya is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Mira Chaurushiya listed at?
Mira Chaurushiya is listed as Managing Director at Westlake BioPartners®. 192 other people in the database share a firm with Mira Chaurushiya.
How do I contact Mira Chaurushiya?
An email address, a phone number and a LinkedIn page are on file for Mira Chaurushiya. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal